Retina
Fake Avastin Hits United States…Again
Fake Avastin has now hit the US market twice in recent months. Are you getting bogus Avastin for your wet ARMD?
Iluvien Gains Ground
Iluvien receives further European approval for the treatment of diabetic macular edema. It has yet to be approved in the U.S. Iluvien is an injected sustained release system.
Social Media RoundTable and Article on Doctors’ Transparency
We just got back from Chicago where we discussed what we've learned on social media and medicine. I also had an article published at KevinMD.com
This Doctor’s View on Social Media and Medicine
We're off to Chicago this weekend to participate on a roundtable to discuss what I've learned from this blog and social media.
Does Cataract Surgery Cause Macular Degeneration?
Sometimes macular degeneration is diagnosed just after successful cataract surgery. These disappointed patients often wonder if AMD is caused by the cataract surgery?
Taking a Break
Most of the kids are on Spring Break. Amy and I took a few days off and are not making lots of plans, but, instead, are taking day trips if we can. The two college kids had their respective breaks 2 -3 weeks ago and each have come and gone back to school. With so [...]
Regular Examination for Retinal Detachments
Routine examination for retinal detachments are usually not worthwhile...even if you had a previous detachment, but if you have symptoms....
Eye Examination for ARMD: Macular Degeneration
Macular degeneration can only be diagnosed when there are symptoms and findings of the disease. Routine examination in normal situations may not be necessary.
When to Get Eye Examinations for Diabetic Retinopathy
All patients with diabetes should get checked for diabetic retinopathy at least annually. This recommendation is supported by the American Academy of Ophthalmology and the American Optometric Association. Diabetic Retinopathy Occurs in Everyone It is likely almost every patient with diabetes will develop some diabetic retinopathy….even if the sugar is well controlled and the A1C [...]
What if I Have Drusen?
Drusen can be normal and do not mean the development of macular degeneration. There are other criteria that are required to make this diagnosis...not just drusen.
Iluvien Marches Forward in Europe
Iluvien, a sustained drug delivery system for the treatment of diabetic macular edema, gets closer to medical use in Europe. This novel treatment for DME remains viable.
Antibiotic Use With Intravitreal Injection Unnecessary
As the number of intravitreal injection procedures increases, so will the incidence of injection-related complications, such as endophthalmitis. Attempting to reduce the rate of postinjection endophthalmitis with prophylactic antibiotics is unnecessary, and might even be counterproductive, according to a study presented here at the World Ophthalmology Congress 2012.
Optogenetic Tool Elucidated
RUB researchers explain channelrhodopsin Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision. The key tool of optogenetics is the light-activated protein channelrhodopsin...
Potential Major Breakthrough in Treatment of Wet Age-Related Macular Degeneration
A single injection of a new gene therapy treatment from Avalanche Biotech could possibly stop the advance of neovascularization in the wet form of AMD for several years. Human clinical trials are currently underway.
Here is how I commented about this breakthrough in my writeup:...
pSivida Corp. Announces Positive Outcome to European Decentralized Procedure for Approval of ILUVIEN® for the Treatment of Chronic Diabetic Macular Edema
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces positive outcome to European Decentralized procedure for approval for ILUVIEN for treatment of chronic diabetic macular edema.
A Novel Gene Therapy Approach to Treating the Wet Form of AMD: The BioFactoryTM From Avalanche Biotech
I originally contacted this company in November 2010, when they were still in “stealth mode” and weren't able to share details about what they were doing. Recently, the company got back in touch to provide an update, having announced, in December 2011, a clinical trial of their gene therapy approach to treating the wet form of AMD.
Extend-and-Treat Bevacizumab Regimen Ups Vision in Wet AMD
Patients with wet age-related macular degeneration who received bevacizumab on an extend-and-treat regimen had significantly improved vision, as well as fewer office visits, tests, and injections.
Medscape Medical News
Medscape Medical News
Genes That Enable Diagnosis Of Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is one of the leading causes of blindness worldwide, especially in developed countries, and there is currently no known treatment or cure or for the vast majority of AMD patients...
New Drug Induces Posterior Vitreous Detachment (PVD)
A potential new drug, ocriplasmin (microplasmin) may soon be available to chemically induce a PVD thus avoiding surgery for many retinal conditions.
Eylea Has Already Begun to Be Used by U.S. Retinal Specialists One Month Post-Launch, According to a Recent BioTrends Report
The LaunchTrends: Eylea Wave 1 report, which measures product uptake and commercial effectiveness at one month post launch, finds that 40% of surveyed retinal specialists have initiated trial on Regenerons Eylea, the newest treatment for wet age-related macular degeneration (wet AMD). One key advantage of Eylea over its main competitors, Genentechs Lucentis and Avastin, is the formal dosing schedule, which allows dosing every eight weeks following an initial three monthly doses...
Subscribe
